William Coley stood helplessly beside Elizabeth “Bessie” Dashiell’s hospital bed when she died on January 23, 1891. When he began treating 17-year-old Bessie four months earlier, he had just completed his surgical internship under two prominent surgeons (William T. Bull and Robert F. Weir) at New York Hospital and had already shown great promise as a surgeon himself.
What impact will AI have on biomedical research over the next few decades? Answers to this question vary wildly. Some prominent scientists have expressed skepticism that AI will have anything more than a marginal effect on the future of research. In contrast, others have argued that we are approaching the “singularity,” wherein the pace of AI development will accelerate exponentially to create a superintelligence far surpassing human abilities, yielding cures to all human diseases in just a few years.
Inspired by ASPET President Randy Hall’s article on artificial intelligence and its potential impact on pharmacology, Executive Officer Dave Jackson discusses how ASPET is—and has been—providing content focused on AI for its members.
ASPET Welcomes New Members
Honoring ASPET members who have passed.
2025 was an undeniably tumultuous year for the science community.
In Industry Insights, members of ASPET’s Industry Science Committee discuss the intersection of pharmacology and industry, private sector highlights, and how the industry and membership can support each other.
A showcase of early-career scientists—what drives them and why pharmacology is important to them.
New ASPET Journal Board Members. The Publications Committee thanks these new editorial board members and all ASPET board members for their service and dedication to the Society’s journals.
